Evidence map›Paper›PMID 38639916›Full record

GuidelineRadiologie (Heidelberg, Germany)2024

[Expert recommendations for magnetic resonance imaging of muscle disorders].

Rachel Zeng, Sarah Schlaeger, Matthias Türk, Thomas Baum, Marcus Deschauer, Rolf Janka, Dimitrios Karampinos, Jan Kassubek, Sarah Keller-Yamamura, Cornelia Kornblum and 14 more

Open access · bronzeAbstract readPractice GuidelineEnglish AbstractReview
PubMed Publisher
In one paragraph

Guideline in Radiologie (Heidelberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 11 institutions in 2 countries.

Rachel ZengKlinik für Neurologie, Universitätsmedizin Göttingen, Göttingen, Deutschland.
Sarah SchlaegerAbteilung für Diagnostische und Interventionelle Neuroradiologie, Klinikum rechts der Isar, Technische Universität München, München, Deutschland, Ismaningerstr. 22, 81675.
Matthias TürkNeurologische Klinik, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Deutschland.
Thomas BaumAbteilung für Diagnostische und Interventionelle Neuroradiologie, Klinikum rechts der Isar, Technische Universität München, München, Deutschland, Ismaningerstr. 22, 81675.
Marcus DeschauerKlinik und Poliklinik für Neurologie, Klinikum rechts der Isar, TUM School of Medicine and Health, Technische Universität München, München, Deutschland.
Rolf JankaRadiologisches Institut, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Deutschland.
Dimitrios KarampinosInstitut für Diagnostische und Interventionelle Radiologie, Klinikum rechts der Isar, Technische Universität München, München, Deutschland.
Jan KassubekKlinik für Neurologie, Universitätsklinikum Ulm, Ulm, Deutschland.
Sarah Keller-YamamuraKlinik für Radiologie, Charité Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Deutschland.
Cornelia KornblumKlinik und Poliklinik für Neurologie, Sektion Neuromuskuläre Erkrankungen, Universitätsklinikum Bonn, Bonn, Deutschland.
Helmar LehmannNeurologische Klinik, Klinikum Leverkusen, akademisches Lehrkrankenhaus der Universität zu Köln, Köln, Deutschland.
Thorsten LichtensteinInstitut für Diagnostische und Interventionelle Radiologie, Medizinische Fakultät und Uniklinik Köln, Universität zu Köln, Köln, Deutschland.
Armin M NagelRadiologisches Institut, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Deutschland.
Jens ReimannKlinik und Poliklinik für Neurologie, Sektion Neuromuskuläre Erkrankungen, Universitätsklinikum Bonn, Bonn, Deutschland.
Angela RosenbohmKlinik für Neurologie, Universitätsklinikum Ulm, Ulm, Deutschland.
Lara SchlaffkeKlinik für Neurologie, BG Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum, Bochum, Deutschland.
Manuel SchmidtNeuroradiologisches Institut, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Deutschland.
Christiane Schneider-GoldNeurologische Klinik und Poliklinik, Katholisches Klinikum Bochum, Bochum, Deutschland.
Benedikt SchoserFriedrich-Baur-Institut an der Neurologischen Klinik und Poliklinik, LMU Klinikum, Ludwig-Maximilians-Universität München, München, Deutschland.
Regina TrollmannZentrum für seltene Erkrankungen Erlangen (ZSEER), Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Deutschland.
Matthias VorgerdKlinik für Neurologie, BG Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum, Bochum, Deutschland.
Marc-André WeberInstitut für Diagnostische und Interventionelle Radiologie, Kinder- und Neuroradiologie, Universitätsmedizin Rostock, Rostock, Deutschland.
Jan S KirschkeAbteilung für Diagnostische und Interventionelle Neuroradiologie, Klinikum rechts der Isar, Technische Universität München, München, Deutschland, Ismaningerstr. 22, 81675. jan.kirschke@tum.de.
Jens SchmidtKlinik für Neurologie, Universitätsmedizin Göttingen, Göttingen, Deutschland. j.schmidt@gmx.org.
Friedrich-Alexander-Universität Erlangen-Nürnberg · DETUM Klinikum · DEBG University Hospital Bergmannsheil Bochum · DEUniversitätsmedizin Göttingen · DEUniversity Hospital Bonn · DEUniversity Hospital Ulm · DEUniversity of Cologne · DECharité - Universitätsmedizin Berlin · DEKatholisches Klinikum Bochum · DELMU Klinikum · DEUniversitätsmedizin Rostock · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMagnetic resonance (MRI) imaging of the skeletal muscles (muscle MRI for short) is increasingly being used in clinical routine for diagnosis and longitudinal assessment of muscle disorders. However, cross-centre standards for measurement protocol and radiological assessment are still lacking.

objectivesThe aim of this expert recommendation is to present standards for the application and interpretation of muscle MRI in hereditary and inflammatory muscle disorders.

methodsThis work was developed in collaboration between neurologists, neuroradiologists, radiologists, neuropaediatricians, neuroscientists and MR physicists from different university hospitals in Germany. The recommendations are based on expert knowledge and a focused literature search.

resultsThe indications for muscle MRI are explained, including the detection and monitoring of structural tissue changes and oedema in the muscle, as well as the identification of a suitable biopsy site. Recommendations for the examination procedure and selection of appropriate MRI sequences are given. Finally, steps for a structured radiological assessment are presented.

conclusionsThe present work provides concrete recommendations for the indication, implementation and interpretation of muscle MRI in muscle disorders. Furthermore, it provides a possible basis for the standardisation of the measurement protocols at all clinical centres in Germany.

Indexed as

Magnetic Resonance ImagingMuscular DiseasesGermanyHumansMuscle, SkeletalDiagnosticsMuscle MRIMyopathyMyositisSemi-quantitative assessment scales

Identifiers

PMID38639916
OpenAlexW4394942606

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.